Zoe Mariñó

4.7k total citations · 1 hit paper
90 papers, 2.5k citations indexed

About

Zoe Mariñó is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Zoe Mariñó has authored 90 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Hepatology, 61 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Zoe Mariñó's work include Hepatitis C virus research (67 papers), Liver Disease Diagnosis and Treatment (47 papers) and Hepatitis B Virus Studies (26 papers). Zoe Mariñó is often cited by papers focused on Hepatitis C virus research (67 papers), Liver Disease Diagnosis and Treatment (47 papers) and Hepatitis B Virus Studies (26 papers). Zoe Mariñó collaborates with scholars based in Spain, United Kingdom and United States. Zoe Mariñó's co-authors include Xavier Forns, Sabela Lens, Miquel Navasa, Gonzalo Crespo, María Reig, Jordi Bruix, Alba Díaz, José Luís Calleja, Christie Perelló and Anna Darnell and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Zoe Mariñó

83 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

2016 725 citations Zoe Mariñó, Sabela Lens et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zoe Mariñó Spain	21	2.1k	1.9k	160	155	152	90	2.5k
Emanuel K. Manesis Greece	33	2.3k 1.1×	2.5k 1.3×	185 1.2×	126 0.8×	150 1.0×	80	3.0k
Chung‐Feng Huang Taiwan	28	2.3k 1.1×	2.3k 1.2×	128 0.8×	171 1.1×	256 1.7×	204	3.2k
Zobair M. Younossi United States	12	1.1k 0.5×	1.0k 0.5×	166 1.0×	80 0.5×	107 0.7×	17	1.6k
Haruhiko Kobashi Japan	24	1.2k 0.6×	1.2k 0.6×	272 1.7×	51 0.3×	108 0.7×	103	1.6k
J. Moussalli France	24	2.3k 1.1×	2.3k 1.2×	105 0.7×	132 0.9×	62 0.4×	56	2.7k
Shingo Nakamoto Japan	23	1.0k 0.5×	844 0.4×	144 0.9×	222 1.4×	245 1.6×	107	1.6k
Massimo Colombo Italy	15	1.3k 0.6×	1.6k 0.9×	185 1.2×	73 0.5×	125 0.8×	26	2.0k
Marie–Pierre Ripault France	20	2.2k 1.1×	2.2k 1.2×	91 0.6×	131 0.8×	86 0.6×	34	2.5k
Spilios Manolakopoulos Greece	32	2.6k 1.2×	2.8k 1.4×	564 3.5×	157 1.0×	162 1.1×	128	3.4k
Makoto Kako Japan	19	831 0.4×	814 0.4×	178 1.1×	128 0.8×	97 0.6×	88	1.4k

Countries citing papers authored by Zoe Mariñó

Since Specialization

Citations

This map shows the geographic impact of Zoe Mariñó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoe Mariñó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoe Mariñó more than expected).

Fields of papers citing papers by Zoe Mariñó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoe Mariñó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoe Mariñó. The network helps show where Zoe Mariñó may publish in the future.

Co-authorship network of co-authors of Zoe Mariñó

This figure shows the co-authorship network connecting the top 25 collaborators of Zoe Mariñó. A scholar is included among the top collaborators of Zoe Mariñó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoe Mariñó. Zoe Mariñó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lorenzen, C. L., Xavier Forns, Anna Sòria, et al.. (2025). Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease. Liver International. 45(5). e70089–e70089. 2 indexed citations

Kelly, Déirdre, José Willemse, Zoe Mariñó, et al.. (2025). Pediatric to adult care transfer in rare liver diseases: Recommendations based on insights from a European omnistakeholder event. JHEP Reports. 7(6). 101403–101403.

Rodríguez‐Tajes, Sergio, Ariadna Rando‐Segura, Zoe Mariñó, et al.. (2025). HBcrAg and cirB‐RNA Do Not Predict Clinical and Virological Outcomes in Patients With HBeAg‐Negative Chronic Infection. Liver International. 45(5). e70072–e70072.

Mariñó, Zoe & Michael L. Schilsky. (2024). Wilson Disease: Novel Diagnostic and Therapeutic Approaches. Seminars in Liver Disease. 45(2). 221–235. 4 indexed citations

Mariñó, Zoe, Célia Bádenas, Jesús Quintero, et al.. (2023). Benefits of using exchangeable copper and the ratio of exchangeable copper in a real‐world cohort of patients with Wilson disease. Journal of Inherited Metabolic Disease. 46(5). 982–991. 11 indexed citations

Sáez‐Peñataro, Joaquín, Raúl J. Andrade, M. Isabel Lucena, et al.. (2023). Anticancer drugs are the first cause of drug‐induced liver injury in a reference hospital. Liver International. 44(2). 286–292. 11 indexed citations

Colom, Joan, José Manuel Goikolea, Isabella Pacchiarotti, et al.. (2023). Low risk of viral hepatitis amongst patients with severe mental disorders. Liver International. 43(6). 1204–1212. 1 indexed citations

Mandorfer, Mattias, Fanny Turón, Sabela Lens, et al.. (2021). Risk of non‐tumoural portal vein thrombosis in patients with HCV‐induced cirrhosis after sustained virological response. Liver International. 41(12). 2954–2964. 5 indexed citations

Rodríguez‐Tajes, Sergio, Josep Costa, Montserrat Laguno, et al.. (2020). Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy. Journal of Viral Hepatitis. 28(1). 89–94. 59 indexed citations

10.

Lens, Sabela, Laura J. Pallett, Barbara Testoni, et al.. (2020). Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients. Journal of Hepatology. 74(5). 1064–1074. 60 indexed citations

11.

Sastre, Lydia, Jordi To‐Figueras, Sabela Lens, et al.. (2020). Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct‐acting anti‐virals. Alimentary Pharmacology & Therapeutics. 51(10). 968–973. 6 indexed citations

12.

Mariñó, Zoe, Sergio Rodríguez‐Tajes, Sabela Lens, et al.. (2020). Improvement of sexuality after hepatitis C cure with direct acting antivirals. Liver International. 40(12). 2972–2977. 2 indexed citations

13.

Lens, Sabela, Anna Baiges, Edilmar Alvarado‐Tápias, et al.. (2020). Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension. Journal of Hepatology. 73(6). 1415–1424. 100 indexed citations

14.

Rodríguez‐Tajes, Sergio, Sabela Lens, Zoe Mariñó, et al.. (2020). Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025. Journal of Hepatology. 73(6). 1360–1367. 13 indexed citations

15.

Rodríguez‐Tajes, Sergio, et al.. (2019). Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak. Journal of Medical Virology. 92(8). 1359–1362. 11 indexed citations

16.

Gambato, Martina, Laëtitia Canini, Sabela Lens, et al.. (2018). Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis. Liver International. 39(5). 826–834. 14 indexed citations

17.

García‐González, Neris, Josep Gregori, Patricia González, et al.. (2018). Hepatitis C virus early kinetics and resistance‐associated substitution dynamics during antiviral therapy with direct‐acting antivirals. Journal of Viral Hepatitis. 25(12). 1515–1525. 5 indexed citations

18.

Bonacci, Martín, Sabela Lens, Zoe Mariñó, et al.. (2018). Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone. Alimentary Pharmacology & Therapeutics. 47(10). 1397–1408. 48 indexed citations

19.

Rodríguez‐Tajes, Sergio, Berta Caballol, Sabela Lens, et al.. (2017). Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January‐June 2017: A hospital perspective. Liver International. 38(4). 588–593. 35 indexed citations

20.

Lens, Sabela, L. Mensa, Martina Gambato, et al.. (2014). HEV infection in two referral centers in Spain; epidemiology and clinical outcomes. Journal of Clinical Virology. 63. 76–80. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact